Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases.

作者: Yassine Riadi , El Hassane Anouar , Alhumaidi B. Alabbas , Mohammed H. Geesi , Ali Altharawi

DOI: 10.1080/07391102.2021.1890221

关键词: Derivative (chemistry)Thio-VEGF receptorsQuinazolinoneStereochemistryDocking (molecular)Tyrosine kinaseBiological evaluationChemistryDual inhibitor

摘要: An efficient process for the preparation of a new ethyl 2-((3-(4-fluorophenyl)-6-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)thio) acetate (5) was described. The prepared derivative synthesized usi...

参考文章(34)
Keilhauer G, Braña Mf, Martín Y, Redondo C, Walker N, Machuca A, Castellano Jm, Schlick E, Benzimidazo[1,2-c]quinazolines: a new class of antitumor compounds. Anti-cancer Drug Design. ,vol. 9, pp. 527- 538 ,(1994)
Baguley Bc, DNA intercalating anti-tumour agents Anti-cancer Drug Design. ,vol. 6, pp. 1- 35 ,(1991)
Leslie R. Pustilnik, Kathleen Provoncha, Kenneth K. Iwata, Erling Emerson, James D. Moyer, John C. Kath, E. Gabriella Barbacci, Jitesh P. Jani, Brian P. Boscoe, Eric D. Cox, Zhengyu Liu, Penny E. Miller, Ann Marie K. Rossi, The Biological and Biochemical Effects of CP-654577, a Selective erbB2 Kinase Inhibitor, on Human Breast Cancer Cells Cancer Research. ,vol. 63, pp. 4450- 4459 ,(2003)
Yuliana Yosaatmadja, Shevan Silva, James M. Dickson, Adam V. Patterson, Jeff B. Smaill, Jack U. Flanagan, Mark J. McKeage, Christopher J. Squire, Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. Journal of Structural Biology. ,vol. 192, pp. 539- 544 ,(2015) , 10.1016/J.JSB.2015.10.018
V. Alagarsamy, V. Raja Solomon, K. Dhanabal, Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 235- 241 ,(2007) , 10.1016/J.BMC.2006.09.065
Michael S. Malamas, Jane Millen, Quinazolineacetic acids and related analogues as aldose reductase inhibitors. Journal of Medicinal Chemistry. ,vol. 34, pp. 1492- 1503 ,(1991) , 10.1021/JM00108A038
Maria K. Gule, Yunyun Chen, Daisuke Sano, Mitchell J. Frederick, Ge Zhou, Mei Zhao, Zvonimir L. Milas, Chad E. Galer, Ying C. Henderson, Samar A. Jasser, David L. Schwartz, James A. Bankson, Jeffrey N. Myers, Stephen Y. Lai, Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model Clinical Cancer Research. ,vol. 17, pp. 2281- 2291 ,(2011) , 10.1158/1078-0432.CCR-10-2762
Jacopo Tomasi, Benedetta Mennucci, Roberto Cammi, Quantum Mechanical Continuum Solvation Models Chemical Reviews. ,vol. 105, pp. 2999- 3094 ,(2005) , 10.1021/CR9904009
Alessandra Antonello, Patrizia Hrelia, Amedeo Leonardi, Gabriella Marucci, Michela Rosini, Andrea Tarozzi, Vincenzo Tumiatti, Carlo Melchiorre, Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds Journal of Medicinal Chemistry. ,vol. 48, pp. 28- 31 ,(2005) , 10.1021/JM049153D